Skip to main content
NEW: MalariaGEN move to LSTM... more
  • Partner Portal
  • Newsletters
  • Use the data
MalariaGEN
  • Home page
  • About
    • About
    • Our approach
      • Using MalariaGEN Data
      • Where we work
      • History
    • Organisms
      • Parasite
      • Mosquito
        • Malaria Vector Genome Observatory
      • Human
    • People
    • Projects
  • Get involved
    • Get involved
    • Partner collaborations
  • Data
    • Data
    • Latest data releases
      • Data archive
    • Studies
  • Tools & Resources
    • Tools & Resources
    • Interpretation Tools
      • Parasite data tools
      • Mosquito data tools
      • Open source software
    • Amplicon toolkit
      • P. falciparum protocols
    • Funding Opportunities
    • Use cases for NMCP’s
    • Ethics
    • Training
  • Impact
    • Impact
    • News
    • Publications
    • Videos & Podcasts
    • Newsletters
  • Search
  • Home page
  • About
    • About
    • Our approach
      • Using MalariaGEN Data
      • Where we work
      • History
    • Organisms
      • Parasite
      • Mosquito
        • Malaria Vector Genome Observatory
      • Human
    • People
    • Projects
  • Get involved
    • Get involved
    • Partner collaborations
  • Data
    • Data
    • Latest data releases
      • Data archive
    • Studies
  • Tools & Resources
    • Tools & Resources
    • Interpretation Tools
      • Parasite data tools
      • Mosquito data tools
      • Open source software
    • Amplicon toolkit
      • P. falciparum protocols
    • Funding Opportunities
    • Use cases for NMCP’s
    • Ethics
    • Training
  • Impact
    • Impact
    • News
    • Publications
    • Videos & Podcasts
    • Newsletters
  • Search
  • Partner Portal
  • Newsletters
  • Use the data
  • Home
  • Impact
  • News

Malaria candidate SNP survey in Mali

Last week, Consortial Project 1 partners published a study exploring the influence of sixty-four malaria candidate SNPs, including the sickle-cell polymorphism (HbS), on severe malaria in a case-control study consisting of over 900 individuals from Bamako, Mali. The findings support known protective effects of the blood group O and the HbS AS genotype in relation to life-threatening malaria as well as demonstrating a marginal susceptibility effect for the CD40 ligand (CD40L)+220C allele.

News 13 Sep 2012
Human

Publication

Toure et al. Candidate Polymorphisms and Severe Malaria in a Malian Population.PLoS One. 2012;7(9):e43987. doi: 10.1371/journal.pone.0043987. Epub 2012 Sep 5.

Latest news and events

Pf amlicon toolkit Article 26 Feb 2026 Building Genomics Capacity for Malaria Surveillance in Africa: Training Resources Identifying training opportunities for genomic epidemiology of malaria.
Newsletter Banner Newsletter 25 Feb 2026 February 2026 MalariaGEN Community Newsletter In this issue: MalariaGEN for Google Summer of Code  | Journal Club | NIHR Career Development | Molecular Parasitology Meeting 2026 | Dream4 Health 
Blog 12 Feb 2026 Ethics, Equity, and Collaboration: How MalariaGEN Supports Fair and Sustainable Genomic Research Championing ethical genomic research through fairness, transparency, and collaboration.

© 2024 MalariaGEN, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SA United Kingdom

  • Sitemap
  • Privacy policy
  • Cookie policy
  • Web design by Chameleon Studios
  • Legal